Fiduciary Rule Changes Require Better Plan Management
… of failing to negotiate lower prices for prescription drugs for its employee health plans – which allegedly resulted in millions of dollars in overpayments for generic drugs. One example cited in the formal complaint alleges that the J&J plan paid $10,200 for a generic multiple sclerosis drug called Teriflunomide, which costs no more than $77 at retail pharmacies. The suit alleges that J&J was negligent in monitoring the activities of their pharmacy benefit manager (PBM), which contracted to pay unreasonable drug costs at the expense of the plan participants and beneficiaries without securing corresponding benefits for them. The
https://www.epicbrokers.com/insights/fiduciary-rules-pharmacy-costs/